{
    "clinical_study": {
        "@rank": "72021", 
        "acronym": "EDITION JP II", 
        "arm_group": [
            {
                "arm_group_label": "New formulation of insulin glargine", 
                "arm_group_type": "Experimental", 
                "description": "once daily in the evening on-top of oral antihyperglycemic drug (OADs)"
            }, 
            {
                "arm_group_label": "Lantus (insulin glargine)", 
                "arm_group_type": "Active Comparator", 
                "description": "once daily in the evening on-top of OADs"
            }
        ], 
        "brief_summary": {
            "textblock": "Primary Objective:\n\n      To compare the efficacy of a new formulation of insulin glargine and Lantus in terms of\n      change of HbA1c from baseline to endpoint (scheduled at month 6 [week 26]) in japanese\n      patients with type 2 diabetes mellitus.\n\n      Secondary Objectives:\n\n      To compare a new formulation of insulin glargine and Lantus in terms of change in fasting\n      plasma glucose (FPG), preinjection plasma glucose, 8-point self-measured plasma glucose\n      (SMPG) profile.\n\n      To compare a new formulation of insulin glargine and Lantus in terms of occurrence of\n      hypoglycemia"
        }, 
        "brief_title": "Comparison of a New Formulation of Insulin Glargine With Lantus\u00ae Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Actual"
        }, 
        "condition": "Type 2 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "The duration of study will consist of:\n\n        -  Up to 2-week screening period;\n\n        -  6-month open-label comparative efficacy and safety treatment period;\n\n        -  6-month open-label comparative safety extension period;\n\n        -  4-week post-treatment safety follow-up period"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria :\n\n        o Patients with type 2 diabetes mellitus diagnosed for at least 1 year at the time of\n        screening visit treated with basal insulin in combination with oral antihyperglycemic\n        drugs (OADs) for at least 6 months before screening visit;\n\n        Exclusion criteria:\n\n          -  Age < 18 years at screening visit;\n\n          -  BMI(body mass index) \u2265 35 kg/m2 at screening visit;\n\n          -  HbA1c < 7.0% or > 10% (national glycohemoglobin standardization program [NGSP] value)\n             at screening visit;\n\n          -  Diabetes other than type 2 diabetes mellitus;\n\n          -  Patients on self-monitoring of blood glucose less than 6 months before screening\n             visit;\n\n          -  Patients using pre-mix insulins, insulin detemir at 2 times or more a day, or GLP 1\n             receptor agonists in the last 3 months before screening visit;\n\n          -  Patients using mealtime insulin (rapid-acting insulin analogue and short-acting\n             insulin) for more than 10 days in the last 3 months before screening visit;\n\n          -  Use of insulin pump in the last 6 months before screening visit;\n\n          -  Initiation of new glucose-lowering medications and/or weight loss drugs in the last 3\n             months before screening visit;\n\n          -  Severe hypoglycemia resulting in coma/seizures, and/or hospitalization for diabetic\n             ketoacidosis in the last 6 months before screening visit;\n\n          -  Unstable proliferative diabetic retinopathy or any other rapidly progressive diabetic\n             retinopathy or macular edema likely to require treatment (eg, laser, surgical\n             treatment or injectable drugs) during the study period.\n\n        The above information is not intended to contain all considerations relevant to a\n        patient's potential participation in a clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01689142", 
            "org_study_id": "EFC12512", 
            "secondary_id": "U1111-1130-3649"
        }, 
        "intervention": [
            {
                "arm_group_label": "New formulation of insulin glargine", 
                "description": "Pharmaceutical form: solution Route of administration: subcutaneous", 
                "intervention_name": "Insulin glargine new formulation (HOE901)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Lantus (insulin glargine)", 
                "description": "Pharmaceutical form: solution Route of administration: subcutaneous", 
                "intervention_name": "Insulin glargine (HOE901)", 
                "intervention_type": "Drug", 
                "other_name": "Lantus"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Glargine", 
                "Insulin", 
                "Hypoglycemic Agents", 
                "Insulin, Long-Acting"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "June 4, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Amagasaki-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392226"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chigasaki-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392218"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chiyoda-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392212"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chuo-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392210"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chuo-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392209"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chuoh-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392208"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ebina-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392217"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fujisawa-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392216"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Higashiosaka-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392222"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Izumisano-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392223"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kamakura-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392215"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kashiwara-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392225"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kawagoe-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392205"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kawaguchi-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392204"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kisarazu-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392206"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Koriyama-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392201"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kurashiki-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392228"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Matsuyama-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392230"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Matsuyama-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392229"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mitaka-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392211"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagoya-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392220"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nishinomiya-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392227"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ogawa-Machi, Hikigun", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392203"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Okawa-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392231"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Osaka-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392224"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shinjuku-Ku", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392207"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shizuoka-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392219"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Takatsuki-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392221"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ushiku-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392202"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yokohama-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392213"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yokohama-Shi", 
                        "country": "Japan"
                    }, 
                    "name": "Investigational Site Number 392214"
                }
            }
        ], 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "2", 
        "official_title": "A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus\u00ae Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus With a 6 Month Safety Extension Period", 
        "overall_official": {
            "affiliation": "Sanofi", 
            "last_name": "Clinical Sciences & Operations", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in HbA1c", 
            "safety_issue": "No", 
            "time_frame": "baseline, 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01689142"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Percentage of HbA1c responders (HbA1c < 7%; < 6.5%)", 
                "safety_issue": "No", 
                "time_frame": "up to 6 months"
            }, 
            {
                "measure": "Change from baseline in FPG", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 months"
            }, 
            {
                "measure": "Change from baseline in pre-basal insulin injection SMPG", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 months"
            }, 
            {
                "measure": "Change from baseline in 8-point SMPG profiles", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 months"
            }, 
            {
                "measure": "Change from baseline in 24-hour mean plasma glucose of SMPG profiles (mean of 8-point values)", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 months"
            }, 
            {
                "measure": "Change from baseline in variability of plasma glucose profile", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 months"
            }, 
            {
                "measure": "Change from baseline in daily basal insulin dose", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 months"
            }, 
            {
                "measure": "Number of patients with various types of hypoglycemia events", 
                "safety_issue": "No", 
                "time_frame": "up to 6 months"
            }
        ], 
        "source": "Sanofi", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sanofi", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}